| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |